A sharp escalation in tensions with the United States has stoked fears in China of a deepening financial war that could result in it being shut out of the global dollar system - a devastating prospect ... ( read original story ...)
Covid-19 vaccine hopeful doubles on China stock market debut
Shares in a pharmaceutical group that is developing a coronavirus vaccine alongside China’s military more than doubled on their trading debut, as investors brushed aside longstanding doubts over ... ( read original story ...)
Cellular Biomedicine Group (CBMG) Reports Q2, H1 2020 Financial Results and Business Highlights
PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies ... ( read original story ...)
Fintech unicorn Lufax, backed by China’s biggest insurer, Ping An, said to be secretly applying for US IPO
Lufax, which runs an online wealth management platform and retail lending technology platform, has hired Bank of America, Goldman Sachs, HSBC and UBS to bring in investors, the people familiar said. A ... ( read original story ...)
China stocks drop most in two weeks on weak global sentiment, bank lending data
Chinese shares fell on Wednesday and were on course for their worst day in over two weeks due to souring global market sentiment and data showing softer growth in bank lending. ** At the midday break, ... ( read original story ...)
Ant Group’s next move: Financial services and beyond?
Ant Group has ambitious plans to build and operate platform business models. At a recent analyst event, they shared their vision and strategy for the future. ( read original story ...)
Ping An Climbs to 21 in the Fortune Global 500 List, 2nd Among Global Financial Enterprises
Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEx:2318; SSE:601318) is number 21 overall in the 2020 Fortune Global 500 list, climbing eight places since last year. With sustained ... ( read original story ...)